Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Assets Average (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Assets Average for 15 consecutive years, with $14.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average rose 6.65% year-over-year to $14.8 million, compared with a TTM value of $14.8 million through Sep 2025, up 6.65%, and an annual FY2024 reading of $15.7 million, down 8.46% over the prior year.
  • Assets Average was $14.8 million for Q3 2025 at China Pharma Holdings, up from $14.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $21.8 million in Q1 2022 and bottomed at $13.9 million in Q3 2024.
  • Average Assets Average over 5 years is $17.0 million, with a median of $16.5 million recorded in 2023.
  • The sharpest move saw Assets Average increased 6.66% in 2022, then fell 19.57% in 2023.
  • Year by year, Assets Average stood at $20.4 million in 2021, then fell by 16.76% to $17.0 million in 2022, then fell by 6.37% to $15.9 million in 2023, then dropped by 10.9% to $14.2 million in 2024, then rose by 4.3% to $14.8 million in 2025.
  • Business Quant data shows Assets Average for CPHI at $14.8 million in Q3 2025, $14.0 million in Q2 2025, and $14.6 million in Q1 2025.